Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SANGAMO THERAPEUTICS, INC | Director | Common Stock | 74.6K | $44.8K | $0.60 | Jun 4, 2024 | Direct |
Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 67K | May 23, 2024 | Direct | ||
SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50K | Jun 4, 2024 | Direct | ||
CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38K | May 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
ABUS | Arbutus Biopharma Corp | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
ABUS | Arbutus Biopharma Corp | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ABUS | Arbutus Biopharma Corp | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Feb 25, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
ABUS | Arbutus Biopharma Corp | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |